XML 94 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation Plans (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restricted Stock [Member]      
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares awarded, beginning of period (in shares) 492,884 489,554 420,234
Non-vested shares that were granted during the period (in shares) 180,178 183,809 247,917
Non-vested shares that vested during period (in shares) (103,515) (139,859) (166,965)
Non-vested shares that forfeited during period (in shares) (30,557) (40,620) (11,632)
Non-vested shares awarded, end of period (in shares) 538,990 492,884 489,554
Share-based Compensation Arrangements by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Weighted Average Grant Date Fair Value, Granted $ 97.56 $ 108.23 $ 73.01
Weighted Average Grant Date Fair Value, Vested 82.85 76.80 94.96
Weighted average grant date fair value non-vested share awards forfeited (in dollars per share) $ 95.17 $ 79.60 $ 75.83
Share-based Compensation Costs, Including Costs That May Be Recognized As Future Expense [Abstract]      
Share-based Compensation Expense Recognized $ 14,800 $ 9,000 $ 9,300
Unrecognized compensation cost of unvested awards, for future periods 22,500    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2024 13,000    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2025 8,400    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2026 $ 1,000    
Number of shares with required performance obligations 136,006    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 10,300 $ 15,000 $ 13,000
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock, Nonvested, Number of Shares [Roll Forward]      
Non-vested shares awarded, beginning of period (in shares) 51,010 87,239 69,669
Non-vested shares that were granted during the period (in shares) 7,275 25,416 17,570
Non-vested shares that vested during period (in shares) (6,894) (61,645) 0
Non-vested shares that forfeited during period (in shares) 0 0 0
Non-vested shares awarded, end of period (in shares) 51,391 51,010 87,239
Share-based Compensation Arrangements by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Weighted Average Grant Date Fair Value, Granted $ 102.35 $ 103.79 $ 88.25
Weighted Average Grant Date Fair Value, Vested 77.36 91.38 0
Weighted average grant date fair value non-vested share awards forfeited (in dollars per share) $ 0 $ 0 $ 0
Share-based Compensation Costs, Including Costs That May Be Recognized As Future Expense [Abstract]      
Share-based Compensation Expense Recognized $ 572 $ 597 $ 4,000
Unrecognized compensation cost of unvested awards, for future periods 1,700    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2024 926    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2025 704    
Unrecognized compensation cost of unvested awards, Amount to be expensed in 2026 $ 25    
Number of shares with required performance obligations 25,210    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested $ 709 $ 6,300 $ 0